The role of p53 redox-modification in cell fate signaling

p53 氧化还原修饰在细胞命运信号传导中的作用

基本信息

  • 批准号:
    8569469
  • 负责人:
  • 金额:
    $ 20.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-07-01 至 2015-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The tumor suppressor p53 is a central hub in multiple cancer-related signaling networks that control cell proliferation and cell fate decisions. However, the more we learn about p53 the more complex and dynamic its role becomes. Recent studies have revealed that p53 is involved in an increasingly diverse range of cellular fates, including necrosis and senescence in addition to apoptosis. The remarkable biochemical complexity of p53 is essential to its diverse physiological roles, yet our understanding of these mechanisms is far from complete. For example, as shown in studies by dozens of laboratories, non-nuclear p53 functions are nearly as important as DNA transactivation with regard to cell fate signaling. In fact, p53 can induce apoptosis in cells through transcription-independent mechanisms even without a functional DNA binding domain, in the absence of RNA synthesis, protein translation, or even without a nucleus. However, the mechanistic details of this process remains much less characterized than classical p53 DNA transactivation response and warrants further investigation. Oxidation-reduction (redox) reactions are essential biochemical processes in many pro- and anti-apoptotic cellular programs that direct cancer cell metabolism, tumor growth, angiogenesis and metastasis. The specificity of these reactions is primarily defined by the high oxidizability of reactive sulfhydryls in select proteins. p53 is a zinc finger protein with ten cysteines, all within its DNA binding domain, and redox-regulated is widely speculated to play a role in its regulation. However, due to technological limitations, nearly all of the studies assessing p53 redox regulation and function have investigated isolated, recombinant protein. There is very little evidence that p53 is redox-regulated in cells on one of its cysteines under physiologically-relevant conditions or stresses. Using a novel mass spectrometry-based redox analysis technology, OxMRM, as well as non-reducing SDS-PAGE, we've discovered that p53 is redox-regulated in a cellular context in response to DNA damage and oxidative stress. These results, along with our biochemical and functional studies, suggest that redox- regulation of p53 is a critical step in cell fate signaling including apoptosis, senescence, and necrosis. This proposal will further characterize the redox-regulation of p53, including 1) identification of the disulfide-linked p53 partner, 2) quantify and define the redox-status of p53 at the mitochondria, and 3) determine the stage of transcription-independent p53 signaling in which redox-regulation is essential. In the long term, altered redox homeostasis is a hallmark of carcinogenesis and may impact p53 function. For example, deregulation of p53 redox-regulation is a potential mechanism by which DNA damaged cells could evade apoptosis and drive tumorigenesis.
描述(由申请人提供):肿瘤抑制因子p53是多种癌症相关信号网络的中心枢纽,控制细胞增殖和细胞命运决定。然而,

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason M. Held其他文献

Erratum: Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma( Nature Biotechnology (2009) 27 (633-641))
勘误表:对血浆中基于多反应监测的蛋白质测量的精度和再现性进行多点评估(Nature Biotechnology (2009) 27 (633-641))
  • DOI:
    10.1038/nbt0909-864b
  • 发表时间:
    2009
  • 期刊:
  • 影响因子:
    46.9
  • 作者:
    T. Addona;Susan E. Abbatiello;B. Schilling;S. Skates;D. Mani;D. Bunk;C. Spiegelman;L. Zimmerman;A. Ham;Hasmik Keshishian;S. Hall;S. Allen;R. K. Blackman;C. Borchers;Charles R. Buck;Helene L. Cardasis;Michael P. Cusack;N. Dodder;B. Gibson;Jason M. Held;Tara Hiltke;A. Jackson;Eric B. Johansen;C. Kinsinger;Jing Li;M. Mesri;T. Neubert;Richard K. Niles;T. Pulsipher;D. Ransohoff;H. Rodriguez;P. Rudnick;Derek Smith;D. Tabb;T. Tegeler;A. Variyath;Lorenzo Vega;Sa Wahlander;S. Waldemarson;Mu Wang;Jeffrey R. Whiteaker;Lei Zhao;N. Anderson;S. Fisher;D. Liebler;A. Paulovich;F. Regnier;P. Tempst;S. Carr
  • 通讯作者:
    S. Carr
receptor alpha, with emphasis on novel phosphorylation sites
受体α,重点是新的磷酸化位点
  • DOI:
  • 发表时间:
    2008
  • 期刊:
  • 影响因子:
    0
  • 作者:
    C. Atsriku;D. Britton;Jason M. Held;B. Schilling;G. Scott;B. Gibson;C. Benz;M. Baldwin
  • 通讯作者:
    M. Baldwin
Using ProteomeScout: A Resource of Post‐Translational Modifications, Their Experiments, and the Proteins That They Annotate
使用 ProteomeScout:翻译后修饰的资源、他们的实验以及他们注释的蛋白质
Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans
大麻素受体的合成配体影响线虫秀丽隐杆线虫的 Dauer 形成
  • DOI:
  • 发表时间:
    2016
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Pedro Reis Rodrigues;Tiffany Kaul;Jo;Mark Lucanic;Kristopher Burkewitz;William B. Mair;Jason M. Held;L. Bohn;M. Gill
  • 通讯作者:
    M. Gill
K 63 Polyubiquitination ErbB 2 Trafficking and Degradation Associated with K 48 and Updated
K 63 多泛素化 ErbB 2 与 K 48 相关的贩运和降解并更新
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    C. Marx;Jason M. Held;B. Gibson;C. Benz
  • 通讯作者:
    C. Benz

Jason M. Held的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason M. Held', 18)}}的其他基金

Investigating GSTP1 as a novel regulator of the cysteine redoxome in breast cancer and maker of vulnerability to redox-based therapy
研究 GSTP1 作为乳腺癌中半胱氨酸氧化还原体的新型调节剂以及氧化还原治疗脆弱性的制造者
  • 批准号:
    10576645
  • 财政年份:
    2022
  • 资助金额:
    $ 20.48万
  • 项目类别:
Using Optogenetics to Dissect the Role of Redox Signaling During C. Elegans Aging
利用光遗传学剖析线虫衰老过程中氧化还原信号的作用
  • 批准号:
    9751694
  • 财政年份:
    2018
  • 资助金额:
    $ 20.48万
  • 项目类别:
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
研究肺癌致瘤性中的 NAPDH 氧化酶和氧化还原信号传导
  • 批准号:
    9283379
  • 财政年份:
    2016
  • 资助金额:
    $ 20.48万
  • 项目类别:
INVESTIGATING NAPDH OXIDASES AND REDOX SIGNALING IN LUNG CANCER TUMORIGENICITY
研究肺癌致瘤性中的 NAPDH 氧化酶和氧化还原信号传导
  • 批准号:
    9175407
  • 财政年份:
    2016
  • 资助金额:
    $ 20.48万
  • 项目类别:
The role of p53 redox-modification in cell fate signaling
p53 氧化还原修饰在细胞命运信号传导中的作用
  • 批准号:
    8680191
  • 财政年份:
    2013
  • 资助金额:
    $ 20.48万
  • 项目类别:
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines
OxMRM:一种量化内源性氧化还原敏感半胱氨酸氧化的技术
  • 批准号:
    7798156
  • 财政年份:
    2009
  • 资助金额:
    $ 20.48万
  • 项目类别:
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines
OxMRM:一种量化内源性氧化还原敏感半胱氨酸氧化的技术
  • 批准号:
    8035283
  • 财政年份:
    2009
  • 资助金额:
    $ 20.48万
  • 项目类别:
OxMRM: A Technique to Quantify Oxidation of Endogenous Redox-Sensitive Cysteines
OxMRM:一种量化内源性氧化还原敏感半胱氨酸氧化的技术
  • 批准号:
    7628935
  • 财政年份:
    2009
  • 资助金额:
    $ 20.48万
  • 项目类别:

相似海外基金

Mechanisms that underlie the life/death decisions in a cell that activated apoptotic caspases
细胞中激活凋亡半胱天冬酶的生/死决策的机制
  • 批准号:
    10607815
  • 财政年份:
    2023
  • 资助金额:
    $ 20.48万
  • 项目类别:
Nuclear and chromatin aberrations during non-apoptotic cell death in C. elegans and mammals
线虫和哺乳动物非凋亡细胞死亡过程中的核和染色质畸变
  • 批准号:
    10723868
  • 财政年份:
    2023
  • 资助金额:
    $ 20.48万
  • 项目类别:
Non-apoptotic functions of caspase-3 in neural development
Caspase-3在神经发育中的非凋亡功能
  • 批准号:
    10862033
  • 财政年份:
    2023
  • 资助金额:
    $ 20.48万
  • 项目类别:
Apoptotic Donor Leukocytes to Promote Kidney Transplant Tolerance
凋亡供体白细胞促进肾移植耐受
  • 批准号:
    10622209
  • 财政年份:
    2023
  • 资助金额:
    $ 20.48万
  • 项目类别:
Design of apoptotic cell mimetic anti-inflammatory polymers for the treatment of cytokine storm
用于治疗细胞因子风暴的模拟凋亡细胞抗炎聚合物的设计
  • 批准号:
    22H03963
  • 财政年份:
    2022
  • 资助金额:
    $ 20.48万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identifying the mechanisms behind non-apoptotic functions of mitochondrial matrix-localized MCL-1
确定线粒体基质定位的 MCL-1 非凋亡功能背后的机制
  • 批准号:
    10537709
  • 财政年份:
    2022
  • 资助金额:
    $ 20.48万
  • 项目类别:
Environmental Carcinogens Induce Minority MOMP to Initiate Carcinogenesis in Lung Cancer and Mesothelioma whileMaintaining Apoptotic Resistance via Mcl-1
环境致癌物诱导少数 MOMP 引发肺癌和间皮瘤的癌变,同时通过 Mcl-1 维持细胞凋亡抵抗
  • 批准号:
    10356565
  • 财政年份:
    2022
  • 资助金额:
    $ 20.48万
  • 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
  • 批准号:
    10708827
  • 财政年份:
    2022
  • 资助金额:
    $ 20.48万
  • 项目类别:
Activation of non-apoptotic cell death by the DNA damage response
DNA 损伤反应激活非凋亡细胞死亡
  • 批准号:
    10388929
  • 财政年份:
    2022
  • 资助金额:
    $ 20.48万
  • 项目类别:
Targeting apoptotic cells to enhance radiotherapy
靶向凋亡细胞以增强放射治疗
  • 批准号:
    10538071
  • 财政年份:
    2022
  • 资助金额:
    $ 20.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了